相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Antibodies as Crypts of Antiinfective and Antitumor Peptides
W. Magliani et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Oxidative stress induces lipid-raft-mediated activation of Src homology 2 domain-containing protein-tyrosine phosphatase 2 in astrocytes
Soo Jung Park et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Cryptococcus neoformans cryoultramicrotomy and vesicle fractionation reveals an intimate association between membrane lipids and glucuronoxylomannan
Debora L. Oliveira et al.
FUNGAL GENETICS AND BIOLOGY (2009)
Brassinosteroid signal transduction from cell-surface receptor kinases to nuclear transcription factors
Tae-Wuk Kim et al.
NATURE CELL BIOLOGY (2009)
Intestinal flora induces the expression of Cyp3a in the mouse liver
T. Toda et al.
XENOBIOTICA (2009)
Finite-element model of interaction between fungal polysaccharide and monoclonal antibody in the capsule of Cryptococcus neoformans
Vineet Rakesh et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2008)
Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence
Marcio L. Rodrigues et al.
EUKARYOTIC CELL (2008)
Dependence of macrophage phagocytic efficacy on antibody concentration
Natasa Macura et al.
INFECTION AND IMMUNITY (2007)
Immunoglobulin light chains generate hydrogen peroxide
Pei-Xuan Wang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport
Marcio L. Rodrigues et al.
EUKARYOTIC CELL (2007)
Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule
Michelle E. Maxson et al.
EUKARYOTIC CELL (2007)
Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance
Oscar Zaragoza et al.
CELLULAR MICROBIOLOGY (2006)
Specific antibody to Cryptococcus neoformans glucurunoxylomannan antagonizes antifungal drug action against cryptococcal biofilms in vitro
Luis R. Martinez et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis
J Pachl et al.
CLINICAL INFECTIOUS DISEASES (2006)
Lipid rafts in Cryptococcus neoformans concentrate the virulence determinants phospholipase B1 and Cu/Zn superoxide dismutase
AR Siafakas et al.
EUKARYOTIC CELL (2006)
Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy
LR Martinez et al.
INFECTION AND IMMUNITY (2005)
Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis
RA Larsen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans
RA Bryan et al.
EUKARYOTIC CELL (2005)
T cell receptor engagement leads to phosphorylation of clathrin heavy chain during receptor internalization
VL Crotzer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Generation of a complement-independent bactericidal IgM against a relapsing fever Borrelia
SE Connolly et al.
JOURNAL OF IMMUNOLOGY (2004)
New concepts in antibody-mediated immunity
A Casadevall et al.
INFECTION AND IMMUNITY (2004)
Melanin from Fonsecaea pedrosoi induces production of human antifungal antibodies and enhances the antimicrobial efficacy of phagocytes
DS Alviano et al.
INFECTION AND IMMUNITY (2004)
Antibody to Cryptococcus neoformans glucuronoxylomannan inhibits the release of capsular antigen
LR Martinez et al.
INFECTION AND IMMUNITY (2004)
The antibody-catalyzed water oxidation pathway - a new chemical arm to immune defense?
J Nieva et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90
RC Matthews et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Passive immunization with melanin-binding monoclonal antibodies prolongs survival of mice with lethal Cryptococcus neoformans infection
AL Rosas et al.
INFECTION AND IMMUNITY (2001)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth
ML Rodrigues et al.
INFECTION AND IMMUNITY (2000)
Biological correlates of capsular (Quellung) reactions of Cryptococcus neoformans
TC MacGill et al.
JOURNAL OF IMMUNOLOGY (2000)